Marsico Capital Management LLC Purchases New Stake in Danaher Corporation $DHR

Marsico Capital Management LLC purchased a new stake in shares of Danaher Corporation (NYSE:DHR) in the 2nd quarter, Holdings Channel reports. The fund purchased 25,306 shares of the conglomerate’s stock, valued at approximately $4,999,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DHR. MGO One Seven LLC raised its stake in Danaher by 485.7% in the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock worth $5,145,000 after purchasing an additional 20,813 shares in the last quarter. Chicago Capital LLC increased its holdings in shares of Danaher by 11.6% during the second quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate’s stock worth $2,634,000 after purchasing an additional 1,391 shares during the period. UniSuper Management Pty Ltd raised its position in shares of Danaher by 1.6% in the first quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock valued at $34,954,000 after buying an additional 2,667 shares in the last quarter. Nvwm LLC boosted its stake in shares of Danaher by 20.4% in the second quarter. Nvwm LLC now owns 7,093 shares of the conglomerate’s stock valued at $1,401,000 after buying an additional 1,204 shares during the period. Finally, ASR Vermogensbeheer N.V. grew its position in Danaher by 1.9% during the second quarter. ASR Vermogensbeheer N.V. now owns 322,924 shares of the conglomerate’s stock worth $63,787,000 after buying an additional 6,136 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total value of $4,773,952.48. Following the completion of the sale, the senior vice president directly owned 14,553 shares of the company’s stock, valued at approximately $3,190,454.19. The trade was a 59.94% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Georgeann Couchara sold 5,174 shares of the company’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the transaction, the senior vice president owned 2,625 shares in the company, valued at $552,352.50. This represents a 66.34% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 30,248 shares of company stock worth $6,609,663 in the last quarter. Company insiders own 11.10% of the company’s stock.

Analysts Set New Price Targets

DHR has been the subject of a number of recent analyst reports. Redburn Partners set a $220.00 target price on Danaher in a research report on Wednesday, October 8th. Wall Street Zen cut shares of Danaher from a “buy” rating to a “hold” rating in a research report on Monday, November 10th. JPMorgan Chase & Co. raised their target price on shares of Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Wells Fargo & Company restated a “positive” rating on shares of Danaher in a research report on Thursday, October 23rd. Finally, Bank of America reduced their price target on shares of Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research report on Monday, September 22nd. Eighteen investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $243.39.

Danaher Stock Up 0.0%

NYSE:DHR opened at $222.44 on Friday. Danaher Corporation has a one year low of $171.00 and a one year high of $258.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. The company has a market cap of $157.12 billion, a PE ratio of 45.86, a P/E/G ratio of 3.28 and a beta of 0.81. The firm’s 50 day simple moving average is $207.83 and its 200 day simple moving average is $201.76.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The firm had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. During the same quarter in the previous year, the company posted $1.71 EPS. The business’s revenue was up 4.4% on a year-over-year basis. On average, research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were paid a $0.32 dividend. The ex-dividend date was Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s payout ratio is currently 26.39%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.